Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...
(RTTNews) - Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the deal, Daiichi Sankyo will acquire world-wide rights ...
As one of the leading Japanese pharmaceutical companies with headquarters in Europe, Daiichi Sankyo aims to revolutionize treatment standards. Daiichi Sankyo, a pharmaceutical group boasting over ...
Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...
On Saturday, November 9, 2024, the official website and X (formerly Twitter) account for Go For It, Nakamura! anime shared the first promotional video. The short clip revealed the anime's main ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
On Saturday, October 19, 2024, the official staff for Go For It, Nakamura! anime shared a new promotional video and visual to confirm the show's 2025 release window. Along with the announcement ...
Tokyo Electric Power Company announced it has successfully completed the trial removal of a sample of fuel debris from the primary containment vessel of unit 2 at the damaged Fukushima Daiichi nuclear ...
SINGAPORE – Barely two weeks after getting his Singapore passport, Kyoga Nakamura received his first call-up on Nov 6 after national football coach Tsutomu Ogura revealed his 26-man squad for ...